The Dangers of Statin Drugs: References

[Guest guest]

http://www.mercola.com/2004/jul/21/statin_drugs_ref.htm

 

The Dangers of Statin Drugs: What You Haven't Been

Told About Cholesterol-Lowering Medication

 

 

References

 

1. Hoffman G. N Engl J Med 1986;314:1610-24

 

2. Eleanor Laise. The Lipitor Dilemma, Smart

Money: The Wall Street Journal Magazine of Personal

Business, November 2003.

 

3. Eleanor Laise. The Lipitor Dilemma, Smart

Money: The Wall Street Journal Magazine of Personal

Business, November 2003.

 

4. Beatrice A. Golomb, MD, PhD on Statin Drugs,

March 7, 2002.

www.coloradohealthsite.org/topics/interviews/golomb.html

 

5. Melissa Siig. Life After Lipitor: Is Pfizer

product a quick fix or dangerous drug? Residents

experience adverse reactions. Tahoe World, January 29,

2004.

 

6. Jamil S, Iqbal P. Heart 2004 Jan;90(1):e3.

 

7. Personal communication, Laura Cooper, May 1,

2003.

 

8. Sinzinger H, O’Grady J. Br J Clin Pharmacol.

2004 Apr;57(4):525-8.

 

9. Smith DJ and Olive KE. Southern Medical Journal

96(12):1265-1267, December 2003.

 

10. Gaist D and others. Neurology 2002 May

14;58(9):1321-2.

 

11. Statins and the Risk of Polyneuropathy.

www.coloradohealthsite.org/CHNReports/statins_polyneuropathy.html.

 

12. The Struggles of Older Drivers, letter by

Elizabeth Scherdt. Washington Post, June 21, 2003.

 

13. Langsjoen PH. The clinical use of HMG Co-A

reductase inhibitors (statins) and the associated

depletion of the essential co-factor coenzyme Q10: a

review of pertinent human and animal data.

http://www.fda.gov/ohrms/dockets/dailys/02/May02/052902/02p-0244-cp00001-02-Exhi\

bit_A-vol1.pdf

 

14. Eleanor Laise. The Lipitor Dilemma, Smart

Money: The Wall Street Journal Magazine of Personal

Business, November 2003.

 

15. Langsjoen PH. The clinical use of HMG Co-A

reductase inhibitors (statins) and the associated

depletion of the essential co-factor coenzyme Q10: a

review of pertinent human and animal data.

http://www.fda.gov/ohrms/dockets/dailys/02/May02/052902/02p-0244-cp00001-02-Exhi\

bit_A-vol1.pdf

 

16. Clark AL and others. J Am Coll Cardiol

2003;42:1933-1943.

 

17. Personal communication, Jason DuPont, MD, July

7, 2003

 

18. Sandra G Boodman. Statins’ Nerve Problems.

Washington Post, September 3, 2002.

 

19. Eleanor Laise. The Lipitor Dilemma, Smart

Money: The Wall Street Journal Magazine of Personal

Business, November 2003,

 

20. King, DS. Pharmacotherapy 25(12):1663-7, Dec,

2003.

 

21. Muldoon MF and others. Am J Med 2000

May;108(7):538-46.

 

22. Email communication, Beatrice Golomb, July 10,

2003.

 

23. Duane Graveline, MD. Lipitor: Thief of Memory,

2004, www.buybooksontheweb.com.

 

24. Lopena OF. Pharm D, Pfizer, Inc., written

communication, 2002. Quoted in an email communication

from Duane Graveline, spacedoc

 

25. Newman TB, Hulley SB. JAMA 1996;27:55-60

 

26. Sacks FM and others. N Eng J Med

1996;385;1001-1009.

 

27. Heart Protection Study Collaborative Group.

Lancet 2002;360:7-22.

 

28. Leung BP and others. J Immunol. Feb 2003

170(3);1524-30; Palinski W. Nature Medicine Dec 2000

6;1311-1312.

 

29. J Pharm Technol 2003;19:283-286.

 

30. Low Cholesterol Linked to Depression. BBC

Online Network, May 25,1999.

 

31. Uffe Ravnskov, MD, PhD. The Cholesterol Myths.

NewTrends Publishing, 2000.

 

32. Ravnskov U. BMJ. 1992;305:15-19.

 

33. Jackson PR. Br J Clin Pharmacol

2001;52:439-46.

 

34. Schatz IJ and others. Lancet 2001 Aug

4;358:351-355.

 

35. Schwartz GG and others. J Am Med Assoc.

2001;285:1711-8.

 

36. The ALLHAT Officers and Coordinators for the

ALLHAT Collaborative Research Group. JAMA

2002;288:2998-3007.

 

37. Heart Protection Study Collaborative Group.

Lancet 2002;360:7-22.

 

38. Medical Research Council/British Heart

Foundation Heart Protection Study.Press release.

Life-saver: World’s largest cholesterol-lowering trial

reveals massive benefits for high-risk patients.

Available at www.ctsu.ox.ac.uk/~hps/pr.shtml.

 

39. Kmietowicz A. BMJ 2001;323:1145

 

40. Ravnskov U. BMJ 2002;324:789

 

41. Email communication, Eddie Vos, February 13,

2004 and posted at

www.health-heart.org/comments.htm#PetoCollins.

 

42. Shepherd J and others. Lancet

2002;360:1623-1630.

 

43. Matsuzaki M and others. Circ J. 2002

Dec;66(12):1087-95.

 

44. Hecht HS, Harmon SM. Am J Cardiol 2003;

92:670-676

 

45. Hecht HS and others. Am J Cardiol

2003;92:334-336

 

46. Jenkins AJ. BMJ 2003 Oct 18;327(7420):933.

 

47. Circulation, 2004 Feb 17;109(6):714-21.

 

48. Sever PS and others. Lancet

2003;361:1149-1158.

 

49. Liu Y and others. JAMA 2004;291:451-459.

 

50. Cannon CP and others. N Engl J Med 2004 Apr

8;350(15):1495-504. Epub 2004 Mar 08.

 

51. Gina Kolata. Study of Two Cholesterol Drugs

Finds One Halts Heart Disease. The New York Times,

November 13, 2003.

 

52. Extra-Low Cholesterol, The New York Times,

March 10, 2003

 

53. Rob Stein. Striking Benefits Found in

Ultra-Low Cholesterol, The Washington Post, March 9,

2004

 

54. Dr. Malcolm Kendrick. PROVE IT- PROVE WHAT?

http://www.redflagsweekly.com/applications/ui/login.php?Next=/kendrick/2004_mar1\

0.php & e=4

 

55. Health Sciences Institute e-alert,

www.hsibaltimore.com, March 11, 2004

 

56. Email communication, Joel Kauffman, April 15,

2004.

 

57. Nissen SE and others. JAMA 2004 Mar

3;291(9):1071-80.

 

58. Dr. Malcolm Kendrick. PROVE IT- PROVE WHAT?

http://www.redflagsweekly.com/applications/ui/login.php?Next=/kendrick/2004_mar1\

0.php & e=4

 

59. Scott Hensley. The Statin Dilemma: How

Sluggish Sales Hurt Merck, Pfizer. The Wall Street

Journal, July 25, 2003.

 

60. Ravnskov, U. Unpublished letter.

ravnskov .

 

61. Cholesterol—And Beyond: Statin Drugs Have Cut

Heart Disease. Now They Show Promise Against

Alzheimer’s, Multiple Sclerosis & Osteoporosis.

Newsweek, July 14. 2003.

 

62. John O’Neil. Treatments: Statins and Diabetes:

New Advice. New York Times, April 20, 2004.

 

63. Peter Jaret. Statins’ Burst of Benefits. Los

Angeles Times, July 2. 2003.

 

64. Behind the ‘Boomer Coalition,’ A Heart Message

from Pfizer, Wall Street Journal, March 10, 2004

 

65. Paul J. Fallon, personal communication, March,

2004.

 

66. Uffe Ravnskov, MD, PhD. The Cholesterol Myths.

NewTrends Publishing, 2000, pp 208-210.